Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

202046 citationsJournal Articlehybrid Open Access

Authors

Yves J. L. Bodar

B.H.E. Jansen · Amsterdam University Medical Centers

J. Patrick van der Voorn · Amsterdam University Medical Centers

Gerben J.C. Zwezerijnen · Amsterdam University Medical Centers

Dennie Meijer · Amsterdam University Medical Centers

Jakko A. Nieuwenhuijzen

Ronald Boellaard · Amsterdam University Medical Centers

N. Harry Hendrikse

Abstract

When comparing the PCa-localisation on <sup>18</sup>F-DCFPyL-PET/CT with the RARP specimens, an accurate per-patient detection (93%) and localisation of csPCa was found. Thus, <sup>18</sup>F-DCFPyL-PET/CT potentially allows for accurate PSMA-targeted biopsy.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Urologic and reproductive health conditions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: World Journal of Urology

Volume 39, Issue 7, pp. 2439-2446

DOI: 10.1007/s00345-020-03490-8

Field-Weighted Citation Impact: 3.42